Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 9 | 2025 | 30 | 1.660 |
Why?
|
| Medicaid | 3 | 2025 | 14 | 1.140 |
Why?
|
| Early Detection of Cancer | 5 | 2024 | 37 | 0.930 |
Why?
|
| Surgical Procedures, Operative | 2 | 2017 | 7 | 0.880 |
Why?
|
| Hematuria | 1 | 2023 | 3 | 0.830 |
Why?
|
| Health Education | 3 | 2016 | 46 | 0.790 |
Why?
|
| African Americans | 4 | 2016 | 256 | 0.630 |
Why?
|
| Humans | 24 | 2025 | 4931 | 0.600 |
Why?
|
| Physicians | 2 | 2017 | 37 | 0.570 |
Why?
|
| Hospitals, Community | 1 | 2017 | 4 | 0.570 |
Why?
|
| Decision Support Techniques | 2 | 2021 | 17 | 0.560 |
Why?
|
| Safety-net Providers | 1 | 2017 | 21 | 0.560 |
Why?
|
| Retrospective Studies | 8 | 2023 | 513 | 0.470 |
Why?
|
| Prostate-Specific Antigen | 5 | 2024 | 7 | 0.470 |
Why?
|
| Primary Health Care | 2 | 2025 | 64 | 0.430 |
Why?
|
| Male | 16 | 2025 | 2620 | 0.420 |
Why?
|
| Aged | 10 | 2024 | 1188 | 0.360 |
Why?
|
| Homeless Persons | 1 | 2010 | 20 | 0.350 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 31 | 0.340 |
Why?
|
| United States | 6 | 2025 | 764 | 0.340 |
Why?
|
| Social Class | 1 | 2010 | 34 | 0.340 |
Why?
|
| Health Status | 1 | 2010 | 61 | 0.340 |
Why?
|
| Health Facility Size | 1 | 2009 | 1 | 0.310 |
Why?
|
| Regional Health Planning | 1 | 2009 | 1 | 0.310 |
Why?
|
| Certification | 1 | 2009 | 3 | 0.310 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 17 | 0.310 |
Why?
|
| Barbering | 3 | 2016 | 4 | 0.300 |
Why?
|
| Health Promotion | 3 | 2016 | 70 | 0.280 |
Why?
|
| Adult | 6 | 2025 | 1402 | 0.280 |
Why?
|
| Middle Aged | 8 | 2024 | 1544 | 0.280 |
Why?
|
| Patient Participation | 2 | 2025 | 23 | 0.270 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2006 | 1 | 0.260 |
Why?
|
| Health Services for the Aged | 1 | 2006 | 5 | 0.260 |
Why?
|
| Drug Prescriptions | 1 | 2006 | 6 | 0.260 |
Why?
|
| Health Policy | 1 | 2006 | 17 | 0.260 |
Why?
|
| Medicare | 1 | 2006 | 45 | 0.250 |
Why?
|
| Remote Consultation | 1 | 2025 | 4 | 0.250 |
Why?
|
| Patient Selection | 1 | 2025 | 31 | 0.230 |
Why?
|
| Healthcare Disparities | 4 | 2025 | 69 | 0.230 |
Why?
|
| Clinical Trials as Topic | 1 | 2025 | 37 | 0.230 |
Why?
|
| Mass Screening | 3 | 2024 | 82 | 0.230 |
Why?
|
| Health Services Accessibility | 1 | 2025 | 124 | 0.220 |
Why?
|
| Mathematics | 1 | 2003 | 1 | 0.210 |
Why?
|
| Referral and Consultation | 1 | 2023 | 45 | 0.200 |
Why?
|
| Cancer Survivors | 1 | 2022 | 4 | 0.200 |
Why?
|
| Body Weight | 1 | 2003 | 80 | 0.200 |
Why?
|
| Health Literacy | 1 | 2022 | 35 | 0.190 |
Why?
|
| Decision Making | 2 | 2021 | 17 | 0.170 |
Why?
|
| Delivery of Health Care | 2 | 2017 | 55 | 0.160 |
Why?
|
| Prostate | 2 | 2022 | 9 | 0.150 |
Why?
|
| Child | 3 | 2011 | 336 | 0.150 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2017 | 6 | 0.140 |
Why?
|
| California | 4 | 2025 | 161 | 0.140 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 34 | 0.140 |
Why?
|
| Female | 6 | 2025 | 2964 | 0.140 |
Why?
|
| Los Angeles | 1 | 2017 | 244 | 0.130 |
Why?
|
| Uncertainty | 1 | 2016 | 2 | 0.130 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 93 | 0.120 |
Why?
|
| Infant | 2 | 2011 | 132 | 0.110 |
Why?
|
| Child, Preschool | 2 | 2011 | 177 | 0.110 |
Why?
|
| Amputation | 1 | 2013 | 1 | 0.110 |
Why?
|
| Ischemia | 1 | 2013 | 4 | 0.110 |
Why?
|
| Vascular Surgical Procedures | 1 | 2013 | 6 | 0.110 |
Why?
|
| Lower Extremity | 1 | 2013 | 6 | 0.110 |
Why?
|
| Hospitalization | 2 | 2011 | 106 | 0.100 |
Why?
|
| Managed Care Programs | 1 | 2013 | 7 | 0.100 |
Why?
|
| Young Adult | 2 | 2011 | 382 | 0.100 |
Why?
|
| Adolescent | 2 | 2011 | 569 | 0.100 |
Why?
|
| Risk Factors | 2 | 2011 | 593 | 0.090 |
Why?
|
| Fractures, Bone | 1 | 2011 | 21 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 76 | 0.090 |
Why?
|
| Budgets | 1 | 2011 | 4 | 0.090 |
Why?
|
| New York City | 1 | 2010 | 10 | 0.090 |
Why?
|
| Residence Characteristics | 1 | 2010 | 27 | 0.090 |
Why?
|
| Community Networks | 1 | 2010 | 4 | 0.080 |
Why?
|
| Thoracic Surgery | 1 | 2009 | 1 | 0.080 |
Why?
|
| General Surgery | 1 | 2009 | 7 | 0.080 |
Why?
|
| Medical Records | 1 | 2009 | 21 | 0.080 |
Why?
|
| Hospitals, Veterans | 1 | 2009 | 9 | 0.080 |
Why?
|
| Social Support | 1 | 2010 | 29 | 0.080 |
Why?
|
| Data Collection | 1 | 2009 | 27 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 16 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 154 | 0.070 |
Why?
|
| Social Change | 1 | 2006 | 3 | 0.070 |
Why?
|
| Cost Savings | 1 | 2006 | 12 | 0.070 |
Why?
|
| Insurance Coverage | 1 | 2006 | 12 | 0.070 |
Why?
|
| Dermatology | 1 | 2025 | 2 | 0.060 |
Why?
|
| Specialization | 1 | 2025 | 14 | 0.060 |
Why?
|
| Papilloma | 1 | 2004 | 1 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 69 | 0.050 |
Why?
|
| Calorimetry | 1 | 2003 | 1 | 0.050 |
Why?
|
| Weight Loss | 1 | 2003 | 32 | 0.050 |
Why?
|
| Glomerular Mesangium | 1 | 2002 | 1 | 0.050 |
Why?
|
| Oxidants | 1 | 2002 | 2 | 0.050 |
Why?
|
| Comprehension | 1 | 2022 | 7 | 0.050 |
Why?
|
| Survivors | 1 | 2022 | 9 | 0.050 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2022 | 7 | 0.050 |
Why?
|
| Curriculum | 1 | 2003 | 44 | 0.050 |
Why?
|
| Glucose | 1 | 2002 | 44 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 144 | 0.050 |
Why?
|
| Incidence | 2 | 2013 | 141 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 202 | 0.050 |
Why?
|
| Reference Values | 2 | 2011 | 41 | 0.050 |
Why?
|
| Apoptosis | 1 | 2002 | 117 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 66 | 0.050 |
Why?
|
| Age Factors | 2 | 2012 | 152 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 407 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 7 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2013 | 14 | 0.030 |
Why?
|
| Logistic Models | 1 | 2013 | 117 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 24 | 0.030 |
Why?
|
| Biopsy | 1 | 2013 | 23 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 30 | 0.030 |
Why?
|
| Prognosis | 1 | 2013 | 167 | 0.020 |
Why?
|
| Markov Chains | 1 | 2011 | 2 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2011 | 7 | 0.020 |
Why?
|
| New York | 1 | 2011 | 5 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 33 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 40 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 121 | 0.020 |
Why?
|
| Models, Economic | 1 | 2011 | 2 | 0.020 |
Why?
|
| Probability | 1 | 2011 | 17 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 23 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 184 | 0.020 |
Why?
|
| Program Development | 1 | 2010 | 28 | 0.020 |
Why?
|
| Benchmarking | 1 | 2009 | 1 | 0.020 |
Why?
|
| Policy Making | 1 | 2009 | 3 | 0.020 |
Why?
|
| Medical Audit | 1 | 2009 | 11 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2009 | 31 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 83 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2004 | 10 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 16 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 3 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 5 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2002 | 10 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 15 | 0.010 |
Why?
|
| Cell Survival | 1 | 2002 | 17 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 11 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 10 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 16 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 33 | 0.010 |
Why?
|
| Cell Line | 1 | 2002 | 82 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2002 | 30 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 126 | 0.010 |
Why?
|
| Mice | 1 | 2002 | 555 | 0.010 |
Why?
|
| Animals | 1 | 2002 | 1369 | 0.010 |
Why?
|